Clinical and Collaborative Care Strategies for the Successful Management of Hemophilia

Register today for the live symposium
Clinical and Collaborative Care Strategies for the Successful Management of Hemophilia

Jointly provided by
    Impact Education, LLC    
This activity is supported by independent educational grants from Alnylam Pharmaceuticals, Shire, and Novo Nordisk, Inc.

Monday, December 5, 2016
11:30 AM - 1:00 PM
Mandalay Bay Convention Center
South Pacific H, North Convention Center
Las Vegas, NV
A Midday Symposium conducted at the 51st ASHP Midyear Clinical Meeting and Exhibition.

Click here to download the slides from this symposium.

This activity is now available as a free on-demand CE activity at:

Up to 1.0 credit available for nurses, pharmacists, and physicians.
  • Updated clinical recommendations for hemophilia, including the role of emerging agents
  • Complications with inhibitor development and its clinical and economic consequences
  • Opportunities to improve communications with Hemophilia Treatment Centers (HTCs)
  • Optimal cost management of factor replacement therapy
Amber Federizo, APRN, FNP-BC
Nurse Practitioner
Hemophilia Treatment Center of Nevada
Surabhi Palkimas, PharmD
Pharmacy Clinical Coordinator, Hematology
University of Virginia Health System

This activity is designed to meet the educational needs of health-system pharmacy professionals attending the 51st ASHP Midyear Clinical Meeting and Exhibition.


Due to the advent of new and more costly treatment modalities, the management of pediatric and adult hemophilia patients has become more complex for health care providers. In the absence of a coordinated educational effort, the full benefits of care coordination and the comprehensive care model have not yet been achieved. Appropriate management is vital to minimizing and preventing long-term issues that can contribute to higher costs. These findings support the need for continued education involving the effective management of patients in a health-system setting. They emphasize the need for a well-coordinated patient management effort, the importance of understanding the most cost-effective ways of using available treatments, and importance of collaboration among all stakeholders, which includes leveraging the comprehensive care model utilized by HTCs. The symposium will provide the latest clinical updates and recommended guidelines and will showcase an interactive case study discussion between the expert faculty panel, which includes an HTC provider and a hemophilia-focused health-system pharmacist.


At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Describe current and evolving strategies for health-system pharmacists to facilitate high quality care for patients with hemophilia
  • Cite the most recent clinical recommendations for the treatment of patients with hemophilia, including investigational agents and the role of novel agents
  • Explain hemophilia-related complications associated with emergency department visits and its significant clinical and economic consequences
  • Identify processes for health-system pharmacists to improve communications and collaborations with hemophilia treatment centers (HTCs)

Date and Time
Monday, December 5, 2016
11:30 AM - 1:00 PM
Mandalay Bay Convention Center
South Pacific H, North Convention Center
Las Vegas, NV

11:30 AM Opening Comments and Pre-activity Assessment
11:35 AM Managing Patients with Hemophilia: Coordinated Care for Optimal Clinical Outcomes
Surabhi Palkimas, PharmD
12:00 PM Optimizing the Pre-Certification and Prior Authorization Process
Amber Federizo, APRN, FNP-BC
12:15 PM Moderated Faculty Panel Discussion
Faculty Panel
12:25 PM Emergency Department Patient Case Study: HTC and Health-System Pharmacy Collaboration - Steps for Success
Amber Federizo, APRN, FNP-BC
Surabhi Palkimas, PharmD
12:45 AM Moderated Faculty Panel Discussion and Audience Q&A
Faculty Panel
1:00 PM Adjournment
Pharmacist Continuing Education
Accreditation Statement
Medical Education Resources (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - 0816-9999-16-080-L01-P

Type of Activity: Knowledge

Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.

Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Meeting Information
Food and beverage are no longer provided at Midday Symposia. This ASHP policy considers the varied internal policies of commercial supporters related to the Physician Payments Sunshine Act. You are welcome to bring your lunch to the session. Preregistration is for planning purposes only and seating will be available on a first come, first served basis.

Fee Information
Please note: No additional fee is required to attend this CPE activity; however, registration to the 51st ASHP Midyear Clinical Meeting and Exhibition is required.

Pre-registration will close at 12:00 pm on December 4, 2016.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email